| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 4.620 | 34.795 | 25.530 | 5.977 | 1.592 | 8.551 | 3.903 | 303 | 864 |
| Total Income - EUR | - | 4.620 | 34.798 | 25.530 | 5.977 | 1.592 | 8.551 | 4.214 | 5.209 | 18.162 |
| Total Expenses - EUR | - | 1.000 | 10.752 | 14.598 | 18.727 | 12.748 | 10.368 | 7.341 | 6.486 | 17.494 |
| Gross Profit/Loss - EUR | - | 3.620 | 24.046 | 10.932 | -12.750 | -11.156 | -1.818 | -3.127 | -1.277 | 668 |
| Net Profit/Loss - EUR | - | 3.482 | 23.002 | 10.397 | -12.929 | -11.204 | -2.074 | -3.244 | -1.277 | 563 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Clujana Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 112 | 15.763 | 51.690 | 41.590 | 30.638 | 22.911 | 23.352 | 17.318 | 104 |
| Current Assets | - | 3.552 | 20.488 | 4.017 | 2.629 | 7.211 | 5.954 | 3.075 | 796 | 750 |
| Inventories | - | 0 | 547 | 537 | 527 | 517 | 0 | 0 | 0 | 0 |
| Receivables | - | 610 | 1.078 | 2.446 | 1.052 | 845 | 98 | 544 | 138 | 34 |
| Cash | - | 2.942 | 18.862 | 1.034 | 1.050 | 5.849 | 5.856 | 2.531 | 658 | 715 |
| Shareholders Funds | - | 3.526 | 26.469 | 13.760 | 564 | -10.651 | -12.489 | -15.772 | -17.001 | -16.343 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 139 | 9.782 | 41.948 | 43.656 | 48.500 | 41.354 | 40.546 | 34.460 | 17.197 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 1.652 | 656 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Clujana Medica Srl